Related Experiment Video
Updated: Apr 19, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.9K
Caffeine inhibits hepatitis C virus replication in vitro.
Mariana N Batista1, Bruno M Carneiro, Ana Cláudia S Braga
1Department of Biology, Institute of Bioscience, Language and Literature and Exact Science, São Paulo State University, IBILCE, UNESP, Rua Cristóvão Colombo 2265, São José do Rio Preto, SP, 15054-000, Brazil.
Archives of Virology
|December 11, 2014
Summary
Caffeine shows promise as a novel Hepatitis C virus (HCV) therapy. This study found caffeine effectively inhibits HCV replication at safe concentrations, suggesting its potential for new anti-HCV treatments.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and hepatocellular carcinoma.
- Current treatments are ineffective against certain HCV genotypes, necessitating novel therapeutic strategies.
- Caffeine has demonstrated potential hepatoprotective effects in various liver conditions.
Purpose of the Study:
- To investigate the direct antiviral effects of caffeine on Hepatitis C virus replication.
- To evaluate caffeine's efficacy and safety as a potential agent for anti-HCV therapies.
Main Methods:
- Utilized the Huh-7.5 cell line for transient infections with a specific HCV construct (FL-J6/JFH-5'C19Rluc2AUbi).
- Established a stable cell line expressing a modified HCV genome (SGR-Feo JFH-1).
- Assessed caffeine's inhibitory effect on viral replication in a dose-dependent manner at non-cytotoxic concentrations.
Main Results:
- Caffeine demonstrated efficient inhibition of HCV replication.
- The inhibition was dose-dependent and occurred at non-cytotoxic concentrations.
- An IC50 value of 0.7263 mM was determined after 48 hours of incubation.
Conclusions:
- Caffeine effectively inhibits Hepatitis C virus replication.
- These findings suggest caffeine's potential as a new therapeutic agent for HCV.
- Caffeine's non-toxic and potent antiviral activity warrants further investigation for clinical application.
More Related Videos
Related Concept Videos
01:25Hepatitis
66
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
66
01:30Inhibitors of Viral Protein Synthesis
47
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
47
02:34Inhibition of Cdk Activity
6.3K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
365
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
365
01:28Viral Hepatitis I: Introduction
15
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
15
01:16Hepatic Drug Excretion: Influencing Factors
789
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
789